Yanna Liu,Zhenyuan Ning,Necati Örmeci,Weimin An,Qian Yu,Kangfu Han,Yifei Huang,Dengxiang Liu,Fuquan Liu,Zhiwei Li,Huiguo Ding,Hongwu Luo,Changzeng Zuo,Changchun Liu,Jitao Wang,Chunqing Zhang,Jiansong Ji,Wenhui Wang,Zhiwei Wang,Weidong Wang,Min Yuan,Lei Li,Zhongwei Zhao,Guangchuan Wang,Mingxing Li,Qingbo Liu,Junqiang Lei,Chuan Liu,Tianyu Tang,Seray Akçalar,Emrecan Çelebioğlu,Evren Üstüner,Sadık Bilgiç,Zeynep Ellik,Özgün Ömer Asiller,Zaiyi Liu,Gaojun Teng,Yaolong Chen,Jinlin Hou,Xun Li,Xiaoshun He,Jiahong Dong,Jie Tian,Ping Liang,Shenghong Ju,Yu Zhang,Xiaolong Qi

Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS">Noninvasive and accurate methods are needed to identify patients with clinically significant portal hypertension (CSPH). We investigated the ability of deep convolutional neural network (CNN) analysis of computed tomography (CT) or magnetic resonance (MR) to identify patients with CSPH.</AbstractText>METHODS: <AbstractText Label="METHODS">We collected liver and spleen images from patients who underwent contrast-enhanced CT or MR analysis within 14 days of transjugular catheterization for hepatic venous pressure gradient measurement. The CT cohort comprised participants with cirrhosis in the CHESS1701 study, performed at 4 university hospitals in China from August 2016 through September 2017. The MR cohort comprised participants with cirrhosis in the CHESS1802 study, performed at 8 university hospitals in China and 1 in Turkey from December 2018 through April 2019. Patients with CSPH were identified as those with a hepatic venous pressure gradient of 10 mm Hg or higher. In total, we analyzed 10,014 liver images and 899 spleen images collected from 679 participants who underwent CT analysis, and 45,554 liver and spleen images from 271 participants who underwent MR analysis. For each cohort, participants were shuffled and then sampled randomly and equiprobably for 6 times into training, validation, and test data sets (ratio, 3:1:1). Therefore, a total of 6 deep CNN models for each cohort were developed for identification of CSPH.</AbstractText>RESULTS: <AbstractText Label="RESULTS">The CT-based CNN analysis identified patients with CSPH with an area under the receiver operating characteristic curve (AUC) value of 0.998 in the training set (95% CI, 0.996-1.000), an AUC of 0.912 in the validation set (95% CI, 0.854-0.971), and an AUC of 0.933 (95% CI, 0.883-0.984) in the test data sets. The MR-based CNN analysis identified patients with CSPH with an AUC of 1.000 in the training set (95% CI, 0.999-1.000), an AUC of 0.924 in the validation set (95% CI, 0.833-1.000), and an AUC of 0.940 in the test data set (95% CI, 0.880-0.999). When the model development procedures were repeated 6 times, AUC values for all CNN analyses were 0.888 or greater, with no significant differences between rounds (P &gt; .05).</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">We developed a deep CNN to analyze CT or MR images of liver and spleen from patients with cirrhosis that identifies patients with CSPH with an AUC value of 0.9. This provides a noninvasive and rapid method for detection of CSPH (ClincialTrials.gov numbers: NCT03138915 and NCT03766880).</AbstractText>

Computer-aided diagnosis of cirrhosis and hepatocellular carcinoma using multi-phase abdomen CT

Deep Liver Lesion AI System: A Liver Lesion Diagnostic System Using Deep Learning in Multiphase CT

A Unified Framework for Preoperative Early Recurrence Prediction of Hepatocellular Carcinoma with Multi-phase CT Images

Deep Fusion Models of Multi-Phase CT and Selected Clinical Data for Preoperative Prediction of Early Recurrence in Hepatocellular Carcinoma.

A Hybrid Approach to Diagnosis of Hepatic Tumors in Computed Tomography Images

Radiological Diagnosis of Chronic Liver Disease and Hepatocellular Carcinoma: A Review

Computer-aided Cirrhosis Diagnosis Via Automatic Liver Capsule Extraction and Combined Geometry-Texture Features.

A Fully Automatic Computer-Aided Diagnosis System for Hepatocellular Carcinoma Using Convolutional Neural Networks

A clinical decision support system for predicting cirrhosis stages via high frequency ultrasound images

Automatic Volumetric Diagnosis of Hepatocellular Carcinoma Based on Four-Phase CT Scans with Minimum Extra Information.

Computer auxiliary diagnosis technique of detecting cholangiocarcinoma based on medical imaging: A review

Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study

Applicability of Multidimensional Convolutional Neural Networks on Automated Detection of Diverse Focal Liver Lesions in Multiphase CT Images.

Automatic Detection of Liver Cancer Using Hybrid Pre-Trained Models

Automatic Diagnosis of Hepatocellular Carcinoma and Metastases Based on Computed Tomography Images

Automated Detection of Primary Liver Cancer Using Different Deep Learning Approaches

Automatic Detection and Classification of Focal Liver Lesions Based on Deep Convolutional Neural Networks: A Preliminary Study

A Cascaded Approach for ultraly High Performance Lesion Detection and False Positive Removal in Liver CT Scans

A Flexible Three-Dimensional Hetero-phase Computed Tomography Hepatocellular Carcinoma (HCC) Detection Algorithm for Generalizable and Practical HCC Screening

Feasibility of automatic detection of small hepatocellular carcinoma (≤2 cm) in cirrhotic liver based on pattern matching and deep learning

Deep Convolutional Neural Network-Aided Detection of Portal Hypertension in Patients With Cirrhosis